Simulations Plus Inc (SLP)

$18.11 -0.12 (-0.66%)
Market Cap 364.83M
Revenue (ttm) 79.18M
Net Income (ttm) -64.72M
EPS (ttm) N/A
PE Ratio 17.70
Forward PE 18.60
Profit Margin -81.74%
Debt to Equity Ratio 0.00
Volume 234,900
Avg Vol 378,052
Day's Range N/A - N/A
Shares Out 20.15M
Stochastic %K 20%
Beta 1.09
Analysts Sell
Price Target $22.33

Company Profile

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on me...

Industry: Health Information Services
Sector: Healthcare
Phone: 661 723 7723
Address:
800 Park Offices Drive, Suite 401, Research Triangle Park, United States
trading_momentum_x
trading_momentum_x Jan. 5 at 3:59 AM
ER run up play this week. $SLP Simulations Plus, Inc. (NASDAQ: SLP) is a U.S.-based software and services company that provides modeling and simulation tools for pharmaceutical research and development. Headquartered in Lancaster, California, its platforms are used to predict drug behavior, optimize dosing, and support regulatory submissions. The company serves pharmaceutical companies, biotech firms, and regulatory agencies worldwide. Buy: $17.62 Sell: $19.00 Stoploss: $16.75 Chart:
0 · Reply
RenewableRexV3
RenewableRexV3 Dec. 26 at 4:40 PM
$SLP Risk appetite is present but conditioned on validation. Balance sheet resilience remains an underappreciated swing factor. Sustained traction could validate the investment case. Stronger outcomes appear only when priorities stay focused.
1 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 12:16 PM
BTIG updates rating for Simulations Plus ( $SLP ) to Neutral.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 11 at 5:05 PM
$SLP Share Price: $20.01 Contract Selected: Jun 18, 2026 $20 Calls Buy Zone: $1.70 – $2.10 Target Zone: $3.04 – $3.71 Potential Upside: 69% ROI Time to Expiration: 188 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Godwins26
Godwins26 Dec. 2 at 9:34 PM
2nd Watchlist for today 😊 $PLRZ it's going to $10 $SMX $THH $TMC $SLP
1 · Reply
topstockalerts
topstockalerts Dec. 2 at 5:00 PM
$SLP Looking good!
0 · Reply
d_risk
d_risk Dec. 2 at 3:50 PM
$SLP - Simulations Plus Inc. Common Stock - 10K - Updated Risk Factors SLP’s 2025 10-K risk factors clarify “clients” over “customers,” sharpen focus on model-informed drug development, highlight AI/ML as both a competitive and legal risk, expand on pricing and demand pressures, detail new government grant and shutdown risks, and note recent share repurchase volatility—no major shifts, but more specificity and new AI, grant, and shutdown disclosures. #ModelInformedDrugDevelopment #ShareRepurchaseVolatility #GovernmentGrants #PricingPressure #AIMLRisks 🟢 Added 🟠 Removed https://d-risk.ai/SLP/10-K/2025-12-01
0 · Reply
ZacksResearch
ZacksResearch Dec. 2 at 2:07 PM
Soft quarter, but is $SLP setting up its next growth phase anyway? SLP’s fiscal Q4 2025 earnings and sales fell year over year, but the company still met full-year goals as cloud, AI, and integrated workflows shape what comes next. Get the full performance breakdown here 👉 https://www.zacks.com/stock/news/2798187/simulations-plus-q4-earnings-sales-meet-estimates-fall-yy?cid=sm-stocktwits-2-2798187-teaser-22981&ADID=SYND_STOCKTWITS_TWEET_2_2798187_TEASER_22981
0 · Reply
ZacksResearch
ZacksResearch Dec. 2 at 1:07 PM
$SLP Q4: A Resilient Pivot Amidst Challenges! 🚀 Despite a 6% revenue dip to $17.5M due to market shifts, $SLP met its fiscal 2025 guidance and grew FY revenues by 13% to $79.2M. Cloud, AI, and integrated workflows are set to drive future growth. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2798187/simulations-plus-q4-earnings-sales-meet-estimates-fall-yy?cid=sm-stocktwits-2-2798187-body-22979&ADID=SYND_STOCKTWITS_TWEET_2_2798187_BODY_22979
0 · Reply
eWhispers
eWhispers Dec. 1 at 6:22 PM
#earnings after the close on Monday, December 1, 2025, and before the open on Tuesday, December 2, 2025 https://www.earningswhispers.com/calendar $CRDO $BNS $MDB $SIG $SLP
0 · Reply
Latest News on SLP
Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development

Dec 18, 2025, 7:50 AM EST - 17 days ago

Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development

Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date

Dec 17, 2025, 7:50 AM EST - 18 days ago

Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date

Simulations Plus Positioned to Capitalize on FDA's Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions

Dec 9, 2025, 7:55 AM EST - 26 days ago

Simulations Plus Positioned to Capitalize on FDA's Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions

Simulations Plus: Buying On Long-Term Silico Drug-Development

Dec 2, 2025, 9:41 PM EST - 4 weeks ago

Simulations Plus: Buying On Long-Term Silico Drug-Development

Simulations Plus Stock Climbs On Earnings Strength, Biotech Market Rebound

Dec 2, 2025, 12:52 PM EST - 4 weeks ago

Simulations Plus Stock Climbs On Earnings Strength, Biotech Market Rebound

Simulations Plus, Inc. (SLP) Q4 2025 Earnings Call Transcript

Dec 1, 2025, 8:13 PM EST - 4 weeks ago

Simulations Plus, Inc. (SLP) Q4 2025 Earnings Call Transcript

Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results

Dec 1, 2025, 4:05 PM EST - 4 weeks ago

Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results

SIMULATIONS PLUS INVESTIGATION: Bragar Eagel & Squire, P.C. Urges Simulations Plus Investors to Contact the Firm Regarding Their Rights

Nov 1, 2025, 10:53 AM EDT - 2 months ago

SIMULATIONS PLUS INVESTIGATION: Bragar Eagel & Squire, P.C. Urges Simulations Plus Investors to Contact the Firm Regarding Their Rights

SLP INVESTORS: Simulations Plus, Inc. Hit with Securities Fraud Investigation after Stock Plummets 26% -- Investors Urged to Contact BFA Law

Oct 24, 2025, 8:38 AM EDT - 2 months ago

SLP INVESTORS: Simulations Plus, Inc. Hit with Securities Fraud Investigation after Stock Plummets 26% -- Investors Urged to Contact BFA Law

Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance

Oct 22, 2025, 7:50 AM EDT - 2 months ago

Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance

SLP STOCK NOTICE: Simulations Plus, Inc. Investors with Losses may have been Affected by Securities Fraud – Contact BFA Law about its Pending Investigation

Oct 22, 2025, 7:09 AM EDT - 2 months ago

SLP STOCK NOTICE: Simulations Plus, Inc. Investors with Losses may have been Affected by Securities Fraud – Contact BFA Law about its Pending Investigation

SLP SECURITIES NEWS: Simulations Plus, Inc. Faces a Securities Fraud Investigation after Stock Drops 26% -- Contact BFA Law if You Suffered Losses

Oct 20, 2025, 8:36 AM EDT - 2 months ago

SLP SECURITIES NEWS: Simulations Plus, Inc. Faces a Securities Fraud Investigation after Stock Drops 26% -- Contact BFA Law if You Suffered Losses

SLP SECURITIES NOTICE: Simulations Plus, Inc. Securities Fraud Investigation is Pending – Contact BFA Law if You Lost Money

Oct 10, 2025, 8:18 AM EDT - 3 months ago

SLP SECURITIES NOTICE: Simulations Plus, Inc. Securities Fraud Investigation is Pending – Contact BFA Law if You Lost Money

SLP FRAUD NOTICE: Simulations Plus, Inc. Hit with Securities Fraud Investigation Due to Impairment Charges -- Contact BFA Law if You Suffered Losses

Oct 8, 2025, 7:36 AM EDT - 3 months ago

SLP FRAUD NOTICE: Simulations Plus, Inc. Hit with Securities Fraud Investigation Due to Impairment Charges -- Contact BFA Law if You Suffered Losses

SLP SHAREHOLDER NOTICE: Simulations Plus, Inc. Investigated for Securities Fraud after 26% Stock Drop – Contact BFA Law

Oct 6, 2025, 8:36 AM EDT - 3 months ago

SLP SHAREHOLDER NOTICE: Simulations Plus, Inc. Investigated for Securities Fraud after 26% Stock Drop – Contact BFA Law

Johnson Fistel Investigates Simulations Plus Following Reports of Financial and Internal Control Issues

Oct 1, 2025, 5:30 PM EDT - 3 months ago

Johnson Fistel Investigates Simulations Plus Following Reports of Financial and Internal Control Issues

Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairment and Auditor Firing-- Hagens Berman

Sep 25, 2025, 2:21 PM EDT - 3 months ago

Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairment and Auditor Firing-- Hagens Berman

SLP SECURITIES NEWS: Why did Simulations Plus, Inc. Stock Drop 26%? Investors with Losses Reminded to Contact BFA Law

Sep 22, 2025, 7:17 AM EDT - 3 months ago

SLP SECURITIES NEWS: Why did Simulations Plus, Inc. Stock Drop 26%? Investors with Losses Reminded to Contact BFA Law

The Bottom Fishing Club - Simulations Plus: Huge Potential In AI Drug Discovery

Sep 22, 2025, 12:00 AM EDT - 3 months ago

The Bottom Fishing Club - Simulations Plus: Huge Potential In AI Drug Discovery

SLP SECURITIES NOTICE: Did Simulations Plus, Inc. Mislead Investors? Contact BFA Law if You Lost Money on Your Investment

Sep 12, 2025, 8:18 AM EDT - 4 months ago

SLP SECURITIES NOTICE: Did Simulations Plus, Inc. Mislead Investors? Contact BFA Law if You Lost Money on Your Investment

Simulations Plus, Inc. (SLP) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 11, 2025, 12:15 PM EDT - 4 months ago

Simulations Plus, Inc. (SLP) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

SLP FRAUD NOTICE: Simulations Plus, Inc. Hit with Securities Fraud Investigation after 26% Stock Drop – Investors Urged to Contact BFA Law

Sep 10, 2025, 7:07 AM EDT - 4 months ago

SLP FRAUD NOTICE: Simulations Plus, Inc. Hit with Securities Fraud Investigation after 26% Stock Drop – Investors Urged to Contact BFA Law

SLP SHAREHOLDERS: Simulations Plus, Inc. Investors may have been Affected by Fraud – Contact BFA Law if You Lost Money (NASDAQ:SLP)

Aug 29, 2025, 7:07 AM EDT - 4 months ago

SLP SHAREHOLDERS: Simulations Plus, Inc. Investors may have been Affected by Fraud – Contact BFA Law if You Lost Money (NASDAQ:SLP)

Simulations Plus to Participate in Upcoming Investor Conferences

Aug 27, 2025, 7:50 AM EDT - 4 months ago

Simulations Plus to Participate in Upcoming Investor Conferences

SLP INVESTOR NOTIFICATION: Simulations Plus, Inc. Investors are Urged to Contact BFA Law about the Pending Securities Fraud Investigation (NASDAQ:SLP)

Aug 27, 2025, 6:46 AM EDT - 4 months ago

SLP INVESTOR NOTIFICATION: Simulations Plus, Inc. Investors are Urged to Contact BFA Law about the Pending Securities Fraud Investigation (NASDAQ:SLP)

Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairments and Grant Thornton Contests Company Statements About Dismissal -- Hagens Berman

Aug 25, 2025, 3:43 PM EDT - 4 months ago

Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairments and Grant Thornton Contests Company Statements About Dismissal -- Hagens Berman

SLP CLASS REMINDER: Suffer Losses on Your Simulations Plus, Inc. Investment? Contact BFA Law about the Securities Fraud Investigation (NASDAQ:SLP)

Aug 23, 2025, 7:08 AM EDT - 4 months ago

SLP CLASS REMINDER: Suffer Losses on Your Simulations Plus, Inc. Investment? Contact BFA Law about the Securities Fraud Investigation (NASDAQ:SLP)

SLP SHAREHOLDER NOTICE: Simulations Plus, Inc. Investors are Notified of the Ongoing Securities Fraud Investigation -- Contact BFA Law if You Suffered Losses (NASDAQ:SLP)

Aug 21, 2025, 8:18 AM EDT - 4 months ago

SLP SHAREHOLDER NOTICE: Simulations Plus, Inc. Investors are Notified of the Ongoing Securities Fraud Investigation -- Contact BFA Law if You Suffered Losses (NASDAQ:SLP)

SLP Investors Have Opportunity to Join Simulations Plus, Inc. Fraud Investigation with the Schall Law Firm

Aug 21, 2025, 4:02 AM EDT - 4 months ago

SLP Investors Have Opportunity to Join Simulations Plus, Inc. Fraud Investigation with the Schall Law Firm

SLP SECURITIES: Simulations Plus, Inc. Shareholders that Lost Money may have been Affected by Fraud -- Contact BFA Law (NASDAQ:SLP)

Aug 19, 2025, 8:36 AM EDT - 4 months ago

SLP SECURITIES: Simulations Plus, Inc. Shareholders that Lost Money may have been Affected by Fraud -- Contact BFA Law (NASDAQ:SLP)

SLP FRAUD REMINDER: Simulations Plus, Inc. Stock Drop Triggers Securities Fraud Investigation – Contact BFA Law if You Lost Money (NASDAQ:SLP)

Aug 15, 2025, 8:18 AM EDT - 5 months ago

SLP FRAUD REMINDER: Simulations Plus, Inc. Stock Drop Triggers Securities Fraud Investigation – Contact BFA Law if You Lost Money (NASDAQ:SLP)

SIMULATIONS PLUS STOCK: Lose Money on Your Simulations Plus, Inc. (NASDAQ:SLP) Investment? Contact BFA Law about its Securities Investigation

Aug 13, 2025, 8:33 AM EDT - 5 months ago

SIMULATIONS PLUS STOCK: Lose Money on Your Simulations Plus, Inc. (NASDAQ:SLP) Investment? Contact BFA Law about its Securities Investigation

Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairments and Grant Thornton Contests Company Statements About Dismissal – Hagens Berman

Aug 12, 2025, 1:29 PM EDT - 5 months ago

Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairments and Grant Thornton Contests Company Statements About Dismissal – Hagens Berman

SLP BREAKING INVESTIGATION: BFA Law Announces an Investigation into Simulations Plus, Inc. after Stock Plummets over 25% on Impairment Charges – Contact BFA Law if You Lost Money

Aug 11, 2025, 3:36 PM EDT - 5 months ago

SLP BREAKING INVESTIGATION: BFA Law Announces an Investigation into Simulations Plus, Inc. after Stock Plummets over 25% on Impairment Charges – Contact BFA Law if You Lost Money

SLP BREAKING NEWS: Simulations Plus, Inc. Stock Significantly Declines After Impairment Charge and Auditor Departure -- Investors Urged to Contact BFA Law

Aug 11, 2025, 3:21 PM EDT - 5 months ago

SLP BREAKING NEWS: Simulations Plus, Inc. Stock Significantly Declines After Impairment Charge and Auditor Departure -- Investors Urged to Contact BFA Law

Simulations Plus and the Institute of Medical Biology of the Polish Academy of Sciences Partnership Announces Results in Validation of ADMET Predictor® Models with Enhanced AI Drug Design

Jul 29, 2025, 7:50 AM EDT - 5 months ago

Simulations Plus and the Institute of Medical Biology of the Polish Academy of Sciences Partnership Announces Results in Validation of ADMET Predictor® Models with Enhanced AI Drug Design

Simulations Plus: Still Positioned For FDA In‑Silico Trend Despite Near‑Term Headwinds

Jul 17, 2025, 5:55 AM EDT - 6 months ago

Simulations Plus: Still Positioned For FDA In‑Silico Trend Despite Near‑Term Headwinds

Simulations Plus Sees Weaker Demand Persist, Outlook Softens

Jul 15, 2025, 1:56 PM EDT - 6 months ago

Simulations Plus Sees Weaker Demand Persist, Outlook Softens

Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Jul 15, 2025, 8:40 AM EDT - 6 months ago

Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

FBK

trading_momentum_x
trading_momentum_x Jan. 5 at 3:59 AM
ER run up play this week. $SLP Simulations Plus, Inc. (NASDAQ: SLP) is a U.S.-based software and services company that provides modeling and simulation tools for pharmaceutical research and development. Headquartered in Lancaster, California, its platforms are used to predict drug behavior, optimize dosing, and support regulatory submissions. The company serves pharmaceutical companies, biotech firms, and regulatory agencies worldwide. Buy: $17.62 Sell: $19.00 Stoploss: $16.75 Chart:
0 · Reply
RenewableRexV3
RenewableRexV3 Dec. 26 at 4:40 PM
$SLP Risk appetite is present but conditioned on validation. Balance sheet resilience remains an underappreciated swing factor. Sustained traction could validate the investment case. Stronger outcomes appear only when priorities stay focused.
1 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 12:16 PM
BTIG updates rating for Simulations Plus ( $SLP ) to Neutral.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 11 at 5:05 PM
$SLP Share Price: $20.01 Contract Selected: Jun 18, 2026 $20 Calls Buy Zone: $1.70 – $2.10 Target Zone: $3.04 – $3.71 Potential Upside: 69% ROI Time to Expiration: 188 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Godwins26
Godwins26 Dec. 2 at 9:34 PM
2nd Watchlist for today 😊 $PLRZ it's going to $10 $SMX $THH $TMC $SLP
1 · Reply
topstockalerts
topstockalerts Dec. 2 at 5:00 PM
$SLP Looking good!
0 · Reply
d_risk
d_risk Dec. 2 at 3:50 PM
$SLP - Simulations Plus Inc. Common Stock - 10K - Updated Risk Factors SLP’s 2025 10-K risk factors clarify “clients” over “customers,” sharpen focus on model-informed drug development, highlight AI/ML as both a competitive and legal risk, expand on pricing and demand pressures, detail new government grant and shutdown risks, and note recent share repurchase volatility—no major shifts, but more specificity and new AI, grant, and shutdown disclosures. #ModelInformedDrugDevelopment #ShareRepurchaseVolatility #GovernmentGrants #PricingPressure #AIMLRisks 🟢 Added 🟠 Removed https://d-risk.ai/SLP/10-K/2025-12-01
0 · Reply
ZacksResearch
ZacksResearch Dec. 2 at 2:07 PM
Soft quarter, but is $SLP setting up its next growth phase anyway? SLP’s fiscal Q4 2025 earnings and sales fell year over year, but the company still met full-year goals as cloud, AI, and integrated workflows shape what comes next. Get the full performance breakdown here 👉 https://www.zacks.com/stock/news/2798187/simulations-plus-q4-earnings-sales-meet-estimates-fall-yy?cid=sm-stocktwits-2-2798187-teaser-22981&ADID=SYND_STOCKTWITS_TWEET_2_2798187_TEASER_22981
0 · Reply
ZacksResearch
ZacksResearch Dec. 2 at 1:07 PM
$SLP Q4: A Resilient Pivot Amidst Challenges! 🚀 Despite a 6% revenue dip to $17.5M due to market shifts, $SLP met its fiscal 2025 guidance and grew FY revenues by 13% to $79.2M. Cloud, AI, and integrated workflows are set to drive future growth. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2798187/simulations-plus-q4-earnings-sales-meet-estimates-fall-yy?cid=sm-stocktwits-2-2798187-body-22979&ADID=SYND_STOCKTWITS_TWEET_2_2798187_BODY_22979
0 · Reply
eWhispers
eWhispers Dec. 1 at 6:22 PM
#earnings after the close on Monday, December 1, 2025, and before the open on Tuesday, December 2, 2025 https://www.earningswhispers.com/calendar $CRDO $BNS $MDB $SIG $SLP
0 · Reply
RunnerSignals
RunnerSignals Nov. 15 at 7:46 AM
Big Upside Stocks to Watch $GEV $MBX $XPEV $APLD $SLP are flashing massive potential! Full pro subscriber analysis reveals who could break out first https://stocksrunner.com/news/2025-11-14-short-term-stocks-with-analyst-upgrades-and-upside
0 · Reply
DocPharm
DocPharm Oct. 29 at 2:09 PM
$SLP going to start a position here; waiting for entry
0 · Reply
lucianw
lucianw Oct. 22 at 8:27 PM
$SLP nice. Finally some movement we deserve. This actually made me more confident about the upcoming ER for some of my other medtech holdings.
0 · Reply
topstockalerts
topstockalerts Oct. 22 at 2:36 PM
$SLP there it goes…
0 · Reply
DaBullRunner
DaBullRunner Oct. 22 at 2:15 PM
$SLP there it goes… SCNX watching closely as this company is the only one I know trading under $1 with TWO FDA approved products 🚨🚨🚨
1 · Reply
SirGeibel
SirGeibel Oct. 22 at 1:56 PM
$SLP why we moving?
0 · Reply
Marklark
Marklark Oct. 22 at 1:41 PM
$SLP sorry guys
0 · Reply
Marklark
Marklark Oct. 21 at 8:05 PM
$SLP ready for the after and ready for tomorrow 😎
0 · Reply
marc1991
marc1991 Oct. 21 at 4:53 PM
$SLP earnings leaked? 390 puts were bought. Very high for this stock.
1 · Reply
Marklark
Marklark Oct. 15 at 11:32 AM
$SLP came on today nice day 😏 pay attention here 🥳
0 · Reply
Marklark
Marklark Oct. 13 at 5:00 PM
$SLP
0 · Reply